Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial.
about
The breast cancer epidemic: 10 factsPhytoestrogens for menopausal vasomotor symptomsLong term hormone therapy for perimenopausal and postmenopausal womenPhytoestrogens for vasomotor menopausal symptomsNon-hormonal therapy for hot flushes in postmenopausal womenEstrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society.Lifestyle changes and the risk of developing endometrial and ovarian cancers: opportunities for prevention and managementThe Important Roles of Steroid Sulfatase and Sulfotransferases in Gynecological DiseasesThe Tumor Macroenvironment: Cancer-Promoting Networks Beyond Tumor BedsTargeting TBP-Associated Factors in Ovarian CancerEstrogen, male dominance and esophageal adenocarcinoma: is there a link?Management of Menopausal Symptoms.A prospective study of postmenopausal hormone use and ovarian cancer riskProgesterone receptors: form and function in brainInsulinotropic effect of the non-steroidal compound STX in pancreatic β-cellsLong-term hormone therapy for perimenopausal and postmenopausal women.Vitamin D suppresses leptin stimulation of cancer growth through microRNA.Menstrual cycle-related exacerbation of diseaseTissue-selective estrogen complex bazedoxifene and conjugated estrogens for the treatment of menopausal vasomotor symptoms.Electroacupuncture promotes insulin-like growth factors system in ovariectomized osteoporosis rats.Long-term postmenopausal hormone therapy and endometrial cancerThe Importance of Steroid Uptake and Intracrine Action in Endometrial and Ovarian Cancers.Estrogen responsiveness of the TFIID subunit TAF4B in the normal mouse ovary and in ovarian tumorsOestrogen receptor beta is involved in the actions of oestrogens in the brain for affective behaviour, but not trophic effects in peripheral tissues.Hormonal contraception and risk of cancer.Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells.Lung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trial.The 2012 hormone therapy position statement of: The North American Menopause Society.Women with familial risk for breast cancer have an increased frequency of aldehyde dehydrogenase expressing cells in breast ductules.A second chance for hormone replacement therapy?Menopausal hormone therapy and cancer: changing clinical observations of target site specificity.Menopausal hormone therapy and risk of endometrial cancer.Scientific rationale for postmenopause delay in the use of conjugated equine estrogens among postmenopausal women that causes reduction in breast cancer incidence and mortality.Increased ovarian cancer risk associated with menopausal estrogen therapy is reduced by adding a progestin.Postmenopausal hormone therapy and the risks of coronary heart disease, breast cancer, and stroke.IMS updated recommendations on postmenopausal hormone therapy.Olive oil in the prevention and treatment of osteoporosis after artificial menopauseRisk factors for ovarian cancer: an overview with emphasis on hormonal factors.Menopausal symptoms and bone health in women undertaking risk reducing bilateral salpingo-oophorectomy: significant bone health issues in those not taking HRT.Comparative evaluation of raloxifene versus estrogen: Progestin on symptomatology, endometrium, and lipid profile in postmenopausal women
P2860
Q22299214-E81A4802-E26E-40EA-993A-A42A7D4525F7Q24201856-15C5F376-1190-4296-B6A1-2D4B871D6E56Q24201974-FB67AA23-D566-4AC5-95EA-1F95E28CCDBAQ24243494-DC4D394A-B398-4B0D-975B-2178B6FDC912Q24246936-AFEDDB55-8F1D-43DB-B23B-AB6A82C63E48Q24658109-B88422F1-784A-4995-BB22-191E1258C01DQ26747160-DFC6D8CF-D698-41B9-8FE4-A6C4AC76FCE2Q26765913-43CBCB36-4E0C-45AE-B567-6D2DB2A8F4B2Q26799120-035AC130-21B9-4978-99EC-4638B3CCE1B5Q26866045-271B9728-01DC-4EAD-BD25-A5721E9D9FE9Q27023016-8AB43AE3-0E4C-4C03-8DDA-B74B70AA4E05Q27318357-AE07D25B-4D2B-4952-8FDA-16959002987AQ28213056-11DC6487-749D-4C84-8422-568B7A6254F5Q28274391-8BF3C5F9-F108-4DF9-8927-741E4A7B50E6Q28482218-B1DFCA66-53EF-4064-A558-456BF812BAF2Q30238978-A19C4ED1-7DA3-47BC-B72D-2C5EA087EF1AQ30367127-C4C00176-5DE2-49C4-A9E1-0C232B3BE5DEQ30431992-51246F25-353B-4549-A612-6C3FB4CAFBB9Q30454254-86B9AF9E-D4CA-4EDB-9BC4-C41EC51B4718Q33389088-794A9B94-847C-4AE2-92B1-6351047BAE6BQ33650188-B2AF1D06-26B4-4418-961B-C6518E107D7BQ33809605-C98F2715-DFE8-4136-8F07-2C13CAEE1B32Q33826212-B8131563-F5EF-4A17-B9CF-04BB538A55F4Q34051348-B3ABC3BE-BCBB-43C2-831C-C62C92928803Q34120493-7709FE0F-B5D3-4DF4-89E5-4434D589304EQ34137268-0C6C38A0-B55C-49B5-87BB-B060597D2247Q34145853-DAD531C8-445A-46E1-B502-06A53683D5A4Q34161400-FEE075A6-39C5-4107-B845-7EAB2A159FABQ34243783-EB009C37-288E-409D-B2B9-A3E5062651D3Q34250612-17159F70-D35B-4C23-BF29-3138C46E37AFQ34315478-920F9253-4F9D-4CF3-BA28-B3497F9F2155Q34345110-7554E58C-6287-4069-9D25-C67AC49B70A6Q34362281-9086530E-3857-4AF4-B1C2-9DD223E010B6Q34372874-F236635E-1079-4E3C-82DC-628AAA6F0BF1Q34420014-9AD444C6-EFCD-4FF8-82BA-03698D1573DCQ34626471-39AC0BC6-85EB-4B3A-8F6A-D8090248BE5EQ34655577-33E0D3F9-A348-48D5-B405-5F97149EC4A2Q34764768-F4FEF2B3-712F-4F59-8D6E-01DBB6624883Q35108393-A20CF542-E3A9-4AE0-AFE0-D544FDE569E4Q35114092-C98D26C1-5285-4DDD-8E4D-14724451F7A8
P2860
Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Effects of estrogen plus proge ...... h Initiative randomized trial.
@en
Effects of estrogen plus proge ...... h Initiative randomized trial.
@nl
type
label
Effects of estrogen plus proge ...... h Initiative randomized trial.
@en
Effects of estrogen plus proge ...... h Initiative randomized trial.
@nl
prefLabel
Effects of estrogen plus proge ...... h Initiative randomized trial.
@en
Effects of estrogen plus proge ...... h Initiative randomized trial.
@nl
P2093
P50
P356
P1476
Effects of estrogen plus proge ...... h Initiative randomized trial.
@en
P2093
Andrew M Kaunitz
David H Barad
Howard L Judd
Mary Pettinger
S Gene McNeeley
Shirley A A Beresford
Women's Health Initiative Investigators
P304
P356
10.1001/JAMA.290.13.1739
P407
P577
2003-10-01T00:00:00Z